Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gualou Xiebai Banxia Decoction + Danshen Decoction for Unstable Angina
NCT03179514Phase 4Unknown
- Start
- Jul 2017
- Primary completion
- Oct 2019
- Modality
- Traditional Chinese Medicine Formula
01
Overview
Phase 4, randomised, open-label trial of Gualou Xiebai Banxia Decoction + Danshen Decoction in unstable angina (2 arms). Primary endpoint: Mortality at 6 months. Status: unknown.
02
Drugs
Gualou Xiebai Banxia Decoction + Danshen Decoction
03
Conditions
unstable angina
Beyond the preview
Go deeper on NCT03179514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03179514.